Article
Directed differentiation of EA/TEF patient-derived induced pluripotent stem cells into…
medRxiv · 2022 · Raad, S.; David, A.; Sagniez, M.; Orfi, Z.; Dumont, N. A.; Smith, M.; Faure, C.
Key facts
| Title | Directed differentiation of EA/TEF patient-derived induced pluripotent stem cells into esophageal epithelial organoids reveal SOX2 dysregulation at the anterior foregut stage |
|---|---|
| First author | Raad, S.; David, A.; Sagniez, M.; Orfi, Z.; Dumont, N. A.; Smith, M.; Faure, C. |
| Journal | medRxiv |
| Published | Feb 16, 2022 |
| DOI | 10.1101/2022.02.14.480418 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, KIT, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1